Breast Cancer with Intracranial Metastases

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-06-02
Clinical Trial Update: Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases [Phase 2]
A Phase 2 study evaluating cabazitaxel plus lapatinib for HER2-positive metastatic breast cancer with intracranial metastases was terminated…